Related references
Note: Only part of the references are listed.Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer
Nicholas M. Mark et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Human CD40 ligand-expressing type 3 innate lymphoid cells induce IL-10-producing immature transitional regulatory B cells
Zsolt I. Komlosi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Alexander C. Huang et al.
NATURE (2017)
Proliferation of PD-1+CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients
Alice O. Kamphorst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy
Norihito Omote et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
Impact of chronic obstructive pulmonary disease on postoperative recurrence in patients with resected non-small-cell lung cancer
Guangliang Qiang et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2016)
Reversing T-cell Dysfunction and Exhaustion in Cancer
Hassane M. Zarour
CLINICAL CANCER RESEARCH (2016)
A retrospective evaluation of associations between chronic obstructive pulmonary disease, smoking, and efficacy of chemotherapy and selected laboratory parameters in patients with advanced non-small cell lung cancer
Rafal Czyzykowski et al.
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy
Rossana Berardi et al.
ONCOTARGET (2016)
Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease
Hanne Astrid Eide et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
Expansion of myeloid-derived suppressor cells in chronic obstructive pulmonary disease and lung cancer: potential link between inflammation and cancer
Sergio Scrimini et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Longitudinal analysis of 2293 NSCLC patients: A comprehensive study from the TYROL registry
Florian Kocher et al.
LUNG CANCER (2015)
Diagnostic Utility of Biomarkers in COPD
Vivek N. Ambade et al.
RESPIRATORY CARE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
T-Regulatory Cells and Programmed Death 1+ T Cells Contribute to Effector T-Cell Dysfunction in Patients with Chronic Obstructive Pulmonary Disease
Suresh Gopi Kalathil et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
The Impact of Coexisting COPD on Survival of Patients With Early-Stage Non-small Cell Lung Cancer Undergoing Surgical Resection
Rihong Zhai et al.
CHEST (2014)
Cisplatin-Induced Antitumor Immunomodulation: A Review of Preclinical and Clinical Evidence
Andreas R. de Biasi et al.
CLINICAL CANCER RESEARCH (2014)
A Correlative Biomarker Analysis of the Combination of Bevacizumab and Carboplatin-Based Chemotherapy for Advanced Nonsquamous Non-Small-Cell Lung Cancer Results of the Phase II Randomized ABIGAIL Study (BO21015)
Tony Mok et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
T helper 17 cells play a critical pathogenic role in lung cancer
Seon Hee Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Persistence of pulmonary tertiary lymphoid tissues and anti-nuclear antibodies following cessation of cigarette smoke exposure
Mathieu C. Morissette et al.
RESPIRATORY RESEARCH (2014)
Plasma vascular endothelial growth factor 165 in advanced non-small cell lung cancer
Ahmed Abdallah et al.
ONCOLOGY LETTERS (2014)
Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors
Jose Luis Izquierdo et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2014)
Control of the immune response by pro-angiogenic factors
Thibault Voron et al.
FRONTIERS IN ONCOLOGY (2014)
The Neutrophil in Chronic Obstructive Pulmonary Disease Too Little, Too Late or Too Much, Too Soon?
Kim Hoenderdos et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy
Yanwen Yao et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
Laurence Zitvogel et al.
IMMUNITY (2013)
High circulating VEGF level predicts poor overall survival in lung cancer
Pingping Hu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
History of myeloid-derived suppressor cells
James E. Talmadge et al.
NATURE REVIEWS CANCER (2013)
Symptoms tell it all: A systematic review of the value of symptom assessment to predict survival in advanced cancer patients
Marija Trajkovic-Vidakovic et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
Imbalance of Th17/Treg cells in mice with chronic cigarette smoke exposure
Huaying Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy
Youngjoo Lee et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Issues surrounding clinical trial endpoints in solid malignancies with a focus on metastatic non-small cell lung cancer
Edward B. Garon
LUNG CANCER (2012)
Lymphocytes in cancer development: Polarization towards pro-tumor immunity
Brian Ruffell et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Cutting Edge: Vascular Endothelial Growth Factor-Mediated Signaling in Human CD45RO+ CD4+ T Cells Promotes Akt and ERK Activation and Costimulates IFN-γ Production
Aninda Basu et al.
JOURNAL OF IMMUNOLOGY (2010)
Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas
Isabelle Ray-Coquard et al.
CANCER RESEARCH (2009)
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients
A. Di Stefano et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Physiology and Therapeutics of Vascular Endothelial Growth Factor in Tumor Immunosuppression
Benjamin Johnson et al.
CURRENT MOLECULAR MEDICINE (2009)
Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03
Satoshi Teramukai et al.
EUROPEAN JOURNAL OF CANCER (2009)
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history
R. P. Young et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study
G. Engstrom et al.
THORAX (2009)
The prognostic significance of vascular endothelial growth factor levees in sera of non-small cell lung cancer patients
A Kaya et al.
RESPIRATORY MEDICINE (2004)
The nature of small-airway obstruction in chronic obstructive pulmonary disease
JC Hogg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury
JP Bridges et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
